We have over 12,000 students, from over 100 countries, within one of the safest campuses in the UK


93% of Lancaster students go into work or further study within six months of graduating

Home > Research > Publications & Outputs > Inter-and intra-individual variations in prosta...
View graph of relations

« Back

Inter-and intra-individual variations in prostate CYP1B1 expression suggest a role in peripheral-zone susceptibility to adenocarcinoma.

Research output: Contribution to journalJournal article


  • Narasimhan Ragavan
  • Rebecca Hewitt
  • Andrew C. Hindley
  • C. M. Nicholson
  • Shyam S. Matanhelia
  • Francis L. Martin
Journal publication date11/2004
Number of pages0
Original languageEnglish


The prostate is conventionally divided into zones. Prostate adenocarcinoma (CaP) is commonly confined to the peripheral zone. Cytochrome P-450 (CYP) isoenzymes are constitutively expressed and inducible enzymes, many of which are involved in hormone and carcinogen hydroxylation. These include the CYP1A1, CYP1A2 and CYP1B1 isoforms. Human prostates (n 5 12) were obtained, with ethical approval, from radical retropubic prostatectomies. Study participants exhibited low PSA (520 mg/l serum) and low volume of disease (5two/eight core biopsies positive for CaP). Following resection, tissue sets consisting of peripheral zone and transition zone were isolated from a lobe pre-operatively identified as negative for CaP. Real-time RT-PCR was employed to quantitatively examine CYP1A1, CYP1A2 and CYP1B1. CYP1A1 expression was quantifiable in either or both zones of nine tissue sets and was unquantifiable in three others. In six tissue sets, higher levels of CYP1A1 expression were observed in the transition zone compared to the peripheral zone. CYP1A2, although detectable, was not quantifiably expressed. CYP1B1 expression was detected in both zones of all tissue sets examined. Interindividual variation in CYP1B1 expression levels in peripheral zone (0.5--2-fold) and transition zone (0.5--5-fold) were noted. In ten tissue sets found to be cancer free, CYP1B1 expression was 2- to 6-fold higher in the peripheral zone compared to the transition zone. In the remaining two tissue sets, CYP1B1 expression was approximately equal in both zones; histopathology showed CaP in one of the zones. CYP1B1 preferentially catalyses the 4-hydroxylation of 17b-oestradiol, metabolically activates exogenous procarcinogens and inactivates anticancer agents. Our results suggest that CYP1B1 may influence susceptibility to CaP.